Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNMCN.L Regulatory News (NMCN)

  • There is currently no data for NMCN

Financing Update

31 Mar 2021 07:01

RNS Number : 0364U
NMCN PLC
31 March 2021
 

31 March 2021

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018

 

NMCN PLC

("nmcn" or "the Company" or "the Group")

 

Financing Update

 

Further to the announcements of 23 and 26 February 2021 the Company, working alongside its debt advisers Arrowpoint Advisory LLP ("Arrowpoint"), is in advanced discussions with a party with a view to concluding a finance package secured against the Company's property development projects. The Board continue to work with Arrowpoint to determine a longer-term financing structure.

The Group is also proactively engaged with Lloyds Bank plc ("Lloyds"), the Company's bank, regarding its existing overdraft facility.

A further update will be made in due course. 

 

 

Enquiries:

 

nmcn Plc - 01623 515008

Ian Elliott, Acting Chairman

Robert Moyle, Acting Chief Executive

Alan Foster, Chief Financial Officer

 

 

 

About nmcn

nmcn Plc (TIDM: NMCN) is a leading engineering and construction company in the UK. Its talented 1,700-strong team offers multi-sector engineering and construction skills, technical innovation, design, and specialist fabrication.

The Company delivers major built environment and water industry projects across the UK - from buildings and highways to large-scale water networks and treatment plants. With its history dating back to 1946, nmcn now has 12 UK offices and three off-site manufacturing facilities.

LEI Number: 213800ANYQVA5OS51A68

www.nmcn.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFVIVLIIVIL
Date   Source Headline
6th Oct 20215:49 pmRNSAppointment of Administrators
4th Oct 20215:30 pmRNSNMCN
4th Oct 202112:26 pmRNSNotice of intention to appoint administrators
1st Oct 20214:19 pmRNSUpdate on publication of the Group's annual report
24th Sep 202110:07 amRNSUpdate on results, refinancing and proposed move
25th Aug 20212:50 pmRNSUpdate on 2020 Results, Prospectus and Circular
2nd Aug 20212:51 pmRNSUpdate on 2020 results
20th Jul 20212:06 pmRNSUpdate on 2020 Result, Financing and Result of GM
15th Jul 20218:21 amRNSGeneral Meeting Details
29th Jun 20218:00 amRNSUpdate on 2020 results, temporary suspension
29th Jun 20217:30 amRNSSuspension - NMCN PLC
24th Jun 20217:00 amRNSPosting of Circular and notice of General Meeting
22nd Jun 20219:05 amRNSSecond Price Monitoring Extn
22nd Jun 20219:00 amRNSPrice Monitoring Extension
21st Jun 20217:00 amRNSFinancing Update
14th Jun 20217:00 amRNSFinancing and Trading Update
7th Jun 20217:00 amRNSHolding(s) in Company
28th May 20212:06 pmRNSSecond Price Monitoring Extn
28th May 20212:00 pmRNSPrice Monitoring Extension
28th May 202111:05 amRNSSecond Price Monitoring Extn
28th May 202111:00 amRNSPrice Monitoring Extension
28th May 20217:00 amRNSFinancing and Trading Update
17th May 20217:00 amRNSAppointment of new Chief Executive Officer
16th Apr 20213:21 pmRNS£8.9m facility concluded & Notice of results
12th Apr 20217:00 amRNSAppointment of new Chief Executive Officer
6th Apr 20217:00 amRNSFinancing Update
31st Mar 20217:01 amRNSFinancing Update
4th Mar 202112:19 pmRNSDirectorate Change
26th Feb 20219:54 amRNSResult of General Meeting
23rd Feb 20211:23 pmRNSTrading Update and Notice of Results
3rd Feb 20217:00 amRNSPosting of Circular and Notice of General Meeting
28th Jan 20217:00 amRNSAppointment of CEO
23rd Dec 202012:00 pmRNSAppointment of Financial Adviser and Broker
23rd Dec 20207:00 amRNSTrading & Board Change Update
28th Oct 20208:23 amRNSAppointment of new Chief Financial Officer
15th Oct 20207:00 amRNSTrading Update
29th Sep 20203:11 pmRNSExternal Auditor Appointment
24th Sep 20204:30 pmRNSBoard Changes and Trading Update
9th Sep 202011:00 amRNSAppointment of Company Secretary
28th Aug 202012:12 pmRNSBoard Changes - Update
7th Aug 20207:04 amRNSProgressive publishes new research
6th Aug 20207:00 amRNSHalf Year Report
24th Jul 202010:00 amRNSBoard Change
25th Jun 20204:19 pmRNSResult of Annual General Meeting
25th Jun 20207:00 amRNSAGM Trading Update
27th May 20207:00 amRNS2019 Report & Accounts & 2020 AGM Notice posted
21st May 20207:00 amRNSDisclosure of rights attached to Equity Shares
4th May 202011:16 amRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNS2019 Final Results & Further COVID-19 Update
14th Apr 202010:00 amRNSFurther Covid-19 Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.